RxDoctor Payments Data

Vadim Morozov, MD

Gynecology · Baltimore, MDNPI 1649393588

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $345,710 of the $393,768 with a category attached, or 87.8%. AbbVie accounts for 75.7% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $165,320 and has fallen 87.0% since, to $21,502 in 2025. Among gynecology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$393,768in general payments, 2019–2025

Across 566 payments — averaging $695.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$298K
  • Covidien LP$29K
  • Davol Inc.$21K
  • Myovant Sciences Inc.$13K
  • Lumenis, Inc$8K
  • Coopersurgical, Inc.$6K
  • plus $18K from 18 others
$141,018in research payments, 2019–2025

Across 16 payments — averaging $8813.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Rejoni Inc.$73K
  • Organon$44K
  • AbbVie$23K
  • Medtronic$875

What the payments were for

  • Consulting fees$6,6952%
  • Speaking & faculty fees$345,71088%
  • Travel & lodging$29,3977%
  • Food & beverage$11,9403%
  • Education$160%
  • Gifts$90%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$393,768 in reported general payments places this provider in the 95th percentile of 79 gynecology providers in Maryland.

See all gynecology providers in Maryland

Medicare billing

Part B allowed, 2024
$13,760
Medicare patients
31
Services billed
58

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gynecology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →